In this issue:
Switching from infliximab to adalimumab in CD
Biologicals and thiopurines for Crohn’s fistulae
Thiopurines prevent advanced neoplasia in IBD
Chronic inflammatory diseases not decreased by helminths
High-dose UDCA in PSC with IBD does not prevent CRC
Please login below to download this issue (PDF)